Get Started

MDEV

BATS First Trust Indxx Medical Devices ETF
Nov 13, 2026 · 3:18 PM ET DELAYED Market Open

$22.65 ↑ +0.08 (+0.35%) Trading Up from the previous close of $22.57, and at the day’s high of $22.65

YTD change
+7.26%
vs 20-day SMA
+2.48%
vs 200-day SMA
+11.56%

Price ranges

Previous day
$22.57 $22.57
open $22.57 close $22.57
+$0.00 (+0.00%)
Today
$22.65 $22.65
open $22.55 now $22.65
+$0.10 (+0.44%)
Past week
$22.57 $22.96
from $22.95 now $22.65
-$0.30 (-1.29%)
Past month
$20.98 $23.32
from $21.03 now $22.65
+$1.62 (+7.70%)
This year
$17.85 $23.32
from $21.12 now $22.65
+$1.53 (+7.26%)

Price & Performance

+4.45 (+24.56%) / 6M

$17.42$19.51$21.59$23.68May 13Aug 7Nov 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 2.9% away from all-time highs of $23.32
  • MDEV is up 7% since the beginning of the year
  • MDEV is up 9% over the past 12 months
  • MDEV is up 8% over the past 1 month

MDEV reads n/a: price sits above both the 20- and 200-day averages, the 12-month move is +9.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeBATS
Sector Wholesale Trade
Sub Sector Merchant Wholesalers, Durable Goods
Market cap N/A

Competitor comparison

TickerCompany PriceChange
FSNUY Fresenius SE & Co. KGaA Sponsored ADR $14.72 +0.02%
SDMHF Sartorius Stedim Biotech SA $245.86 -2.45%
FSPKF Fisher & Paykel Healthcare Corporation Limited $26.99 -0.07%
HSIC Henry Schein, Inc. $86.14 -2.58%
EKTAF Elekta AB Class B $6.11 -0.16%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.